Skip to main content
Clinical Trials/DRKS00025048
DRKS00025048
Recruiting
未知

ower respiratory tract Microbiome in patients with Lung cancer (LML)

niversitätsklinikum FreiburgKlinik für Thoraxchirurgie0 sites150 target enrollmentOctober 13, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
C34
Sponsor
niversitätsklinikum FreiburgKlinik für Thoraxchirurgie
Enrollment
150
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 13, 2021
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum FreiburgKlinik für Thoraxchirurgie

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients with a) suspected or proven lung cancer (study group) or b) COPD (control
  • 2\. scheduled for bronchoscopy and/or surgical resection at the Medical Center Freiburg
  • 3\. Male and female patients, \= 18 years of age

Exclusion Criteria

  • 1\. Patients with history of systemic corticosteroids and/or immunosuppressive therapy in the last 12 months before enrolment
  • 2\. Patients with history of systemic antibiotics for any reason in the last 4 weeks before enrolment
  • 3\. Patients with history of chemotherapy and/or radiation

Outcomes

Primary Outcomes

Not specified

Similar Trials